EYE NATIONAL VISION HOLDINGS INC
2026Q1 · CUSIP 63845R107 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
255
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
138
Δ whales
+1
Inst. holding value
$2.5B
New positions
35
Closed positions
42
Price momentum (1Q)
-37.6%
Put / Call
5/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 19% | +11.2% | -31.2% |
| 2025Q2 | Top 8% | -0.7% | +13.4% |
| 2025Q1 | Top 14% | +22.8% | +27.3% |
| 2023Q2 | Top 19% | -2.2% | +6.5% |
| 2022Q3 | Top 7% | +1.5% | -38.9% |
| 2020Q3 | Top 16% | +16.2% | +13.3% |
| 2019Q2 | Top 10% | -2.5% | +27.8% |
| 2018Q3 | Top 2% | -14.7% | -29.0% |
| 2018Q1 | Top 12% | +14.6% | +20.7% |
Options Sentiment
Put holders
5
QoQ: +4
Call holders
4
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
34.8
EPS (TTM)
$0.57
EPS YoY
—
Revenue (TTM)
$2.0B
Revenue YoY
+9.2%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-04-04 · SEC filings (XBRL)